53
Participants
Start Date
February 4, 2019
Primary Completion Date
November 8, 2021
Study Completion Date
September 30, 2026
Mobocertinib
Mobocertinib capsule.
Aichi Cancer Center Hospital, Nagoya
Fujita Health University Hospital, Toyoake
National Cancer Center Hospital East, Kashiwa
Kurume University Hospital, Kurume
Hokkaido Cancer Center, Sapporo
Hyogo Cancer Cente, Akashi
Kanazawa University Hospital, Kanazawa
Kanagawa Cancer Center, Yokohama
Sendai Kousei Hospital, Sendai
Okayama University Hospital, Kita-ku
Kansai Medical University Hospital, Hirakata
National Hospital Organization Kinki-Chuo Chest Medical Center, Sakai
Kindai University Hospital, Sayama
Saitama Cancer Center, Shinden
Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Bunkyo-ku
National Cancer Center Hospital, Chuo-ku
Cancer Institute Hospital, Koto-ku
Yamaguchi Ube Medical Center, Ube
Kyushu University Hospital, Fukuoka
Hiroshima University Hospital, Hiroshima
Kyoto University Hospital, Kyoto
Niigata Cancer Center Hospital, Niigata
Osaka International Cancer Institute, Osaka
Tokushima University Hospital, Tokushima
Wakayama Medical University Hospital, Wakayama
Lead Sponsor
Takeda
INDUSTRY